Novavax Inc. – Filings and Transcripts

NASDAQ: NVAX
Share price (3/17/26): $10.64
Market cap (3/17/26): $1.734 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Automatic shelf registration

Registration of securities for employees

Ownership Filter

Kelly James Patrick

Kelly James Patrick

Draghia-Akli Ruxandra

News Filter

Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Material Definitive Agreement

Investor Presentation

Reports Third Quarter 2025 Financial Results and Operational Highlights

Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Proxy materials by non-management

Proxy materials by non-management

Other Filter

Scanned paper annual report submission

Letter from the SEC

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness